Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients. (13th September 2016)

• Record Type: Journal Article
• Authors: Yoon, Lara; Clarke Hillyer, Grace; Chen, Ling; Hu, Jim C.; Neugut, Alfred I.; Hershman, Dawn L.; Wright, Jason D.
• Is Part Of: Cancer investigation. Volume 34:Number 8(2016)
• Page Start: 408
• Page End: 414
• Publication Date: 2016-09-13
• Subjects: Venous thromboembolism -- inferior vena cava filter -- thrombectomy -- thrombolysis; Cancer -- Periodicals; Oncology -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- Periodicals; 616.994
• DOI: 10.1080/07357907.2016.1221078
• Languages: English
• ISSNs: 0735-7907

Abstract

ABSTRACT: Venous thromboembolic disease is a major cause of morbidity in cancer patients. The Perspective database was used to identify patients with solid tumors and a diagnosis of VTE from 2006 to 2012. We examined use of IVC filters, thrombolysis, and thrombectomy. Among 32, 545 patients, 23.1% received an IVC filter, 1.9% thrombolytic therapy, and 0.4% underwent thrombectomy. Use of IVC filters decreased between 2006 and 2012 (23.4% to 21.2%, p = 0.012). Older patients, uninsured patients, Hispanics, and those with more comorbidities were more likely to undergo filter placement while patients at rural hospitals were less likely to receive an IVC filter ( p < 0.05 for all).